Point72 Asset Management
DFTX

Point72 Asset Management’s Definium Therapeutics DFTX Stock Holding History

Point72 Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Sell
175,490
-4,951
-3% -$84K ﹤0.01% 1972
2025
Q4 		$2.42M Sell
180,441
-43,859
-20% -$543K ﹤0.01% 2358
2025
Q3 		$2.64M Buy
+224,300
New +$2.09M ﹤0.01% 1333

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's DFTX Position: Q1 2026 in Review

Point72 Asset Management reduced its Definium Therapeutics (DFTX) stake by 2.7% in Q1 2026, selling an estimated $84K and leaving 175,490 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

Point72 Asset Management first reported a position in DFTX in Q3 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Point72 Asset Management held 175,490 shares of Definium Therapeutics worth $3.32M as of Q1 2026.
  • Point72 Asset Management sold 4,951 Definium Therapeutics shares in Q1 2026, an estimated $84K.
  • Definium Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1972 holding.
  • Point72 Asset Management first reported a position in Definium Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.